Clinical Trials Logo
  1. Home
  2. Uterine Leiomyoma
  3. NCT01738724

Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin

Uterine Leiomyoma Clinical Trial

Official title:
Abnormal Uterine Bleeding in Women With Uterine Leiomyomas: Open Randomized Clinical Trial Of Non Inferiority Between Oral Dienogest, Oral Desogestrel and Subcutaneous Goserelin

Clinical Trial Summary

The investigators´aim is to assess whether the progestagen dienogest reduces leiomyoma volume and its associated symptoms to the same extent as gonadotropin releasing hormone (GnRH) analogs or the progestagen desogestrel or whether it is inferior to other drugs already in use.

Clinical Trial Description

Uterine leiomyoma is a very prevalent condition among women and, although it is mainly asymptomatic, it may be related to bothersome or debilitating symptoms, such as uterine bleeding and pelvic pain or pressure. The standard treatment is surgical (hysterectomy or myomectomy), but there has been continued interest on medical treatments. Progestagens have long been used to control bleeding associated to leiomyomas, but they have not been able to decrease myoma volume. GnRH analogs are well stablished agents, capable of controlling symptoms and decreasing the tumors´volume, but their use is limited by bone loss and menopausal symptoms. A newly introduced progestagen, dienogest, has been studied to treat endometriosis, but its effects on leiomyoma are only starting to be assessed. The investigators are aiming to compare dienogest with the GnRH analog goserelin and the progestagen desogestrel in a randomized trial to see how this new treatment compares with previously used drugs and whether it is similar, inferior or superior to them on controlling leiomyoma associated symptoms and decreasing leiomyoma volume. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01738724
Study type Interventional
Source University of Sao Paulo
Contact
Status Terminated
Phase Phase 4
Start date January 2012
Completion date December 2017
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04519593 - ABSOLUTELY: A Temporary Uterine Blood Supply Occlusion for Laparoscopic Myomectomy in Patients With UTErine LeiomYoma N/A
Not yet recruiting NCT03219385 - Directed Ablation of Uterine Fibroids Using a Noninvasive Approach N/A
Completed NCT01338831 - Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer Phase 1
Completed NCT01468402 - Predictive Factors of Pelvic Magnetic Resonance in the Response of Arterial Embolization of Uterine Leiomyoma N/A
Completed NCT03847077 - Trial of a Patient Education Tool For Leiomyoma N/A
Completed NCT00365989 - MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication Phase 3
Completed NCT03751124 - Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids Phase 3
Recruiting NCT02495311 - The Association Between Adenomyosis/Uterine Myoma and Lower Urinary Tract Symptoms
Completed NCT00332033 - Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids) Phase 2
Completed NCT04874246 - Comparison of Concentration of Vasopressin During Robot-assisted Laparoscopic Myomectomy N/A
Not yet recruiting NCT04282863 - Comparison Between Robotic (RM) and Laparoscopic Myomectomy (LM) N/A
Recruiting NCT06115408 - Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma Phase 2/Phase 3
Completed NCT02049242 - Uterine Tourniquet at Open Myomectomy N/A
Completed NCT02059954 - Vaginal vs. Laparoscopic Hysterectomy N/A
Terminated NCT01280045 - Influence of Aromatase Inhibitors and GnRH Analogs to Treat Uterine Leiomyoma by Vaginal Hysterectomy N/A
Withdrawn NCT02736435 - Treatment of Uterine Fibroids With Magnetic Resonance Guided High Intensity Focused Ultrasound Phase 3
Completed NCT04819633 - Evaluating Serum Sestrin in Leiomyoma Patients
Completed NCT00341848 - Postpartum Uterine Regression
Completed NCT01715597 - Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma Phase 3
Completed NCT03328260 - High Intensity Focused Ultrasound in Uterine Myoma N/A